chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had minor headache 2 days after vaccine that progressed into temporal migraine. After 2-3 days of pain, the migraine turned into a vestibular migraine in which I had severe dizziness, blurred vision, and loss of vision. This lasted for 6 days (1/5/2021-1/10/2021).
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 07-SEP-2016, the patient was vaccinated with improperly stored (Oka/Merck) VARIVAX subcutaneously (dose not reported) from lot # L042267 with expiry date of 27-OCT-2017 which was exposed to a temperature excursion of 44 degree Fahrenheit (F) for 1 hour, -14.86 degree Celsius (C) for 1 minute, 8.36 F for 1 hour and -14.23 C for 1 hour. No adverse effects were reported. There was no previous temperature excursion. Digital data logger was involved. No product quality complaint was involved. This is one of the two reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to a 28 year old female patient. Medical history, concurrent conditions and concomitant medications were not reported. Approximately on an unknown dates when the patient was 26 years or younger, she was vaccinated with first and the second dose of GARDASIL series intramuscularly. On 26-JUN-2015 (reported as today), the patient was in the office to receive her third dose of GARDASIL and now she was 28 years old. No adverse effect was reported. Action taken was not applicable. The outcome of Inappropriate schedule of drug administration and No adverse effect was unknown. Additional information has been requested.
little soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little soreness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included LORATADINE for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN IN EXTREMITY (little soreness). At the time of the report, PAIN IN EXTREMITY (little soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details were provided.
Vaccination rec'd 08/11/16. 24 hours post-vaccination, patient developed a red, swollen area below the vaccination site. 48 hours later - reddish purple swelling in upper arm, warm to the touch and painful. Patient described area as tight feeling. Patient saw her Dr on 8/15 - Pt says it was a "skin rash". Symptoms resolved as of 8/16.
Immediate chills / dripping sweat after injection. Subsided about 15 minutes after. Have since had extreme fatigue, body aches, fever, soreness, congestion, and most notably a rash developing all over the chest area.
Extreme chills lasting approx 2 hours Nausea briefly Fatigue  ongoing
Moderate, continuous lower back pain one hour after injection. Vision slightly blurred. No fever as of 8:09 pm.
On 10/1/2021 received my booster shot.  The night of 10/2/2021 I felt tenderness  in my armpit as of 10/04/21 the tenderness has increased.  Employee health at my work where I received the vaccine told me to put warm compress and take Tylenol or Ibuprofen.
about 6 hours post vaccine I started having chills and a headache. 11 hours post vaccine my hands became paralyzed in severe contracture. My face and feet and legs were number. I could barely breathe. I had to be transferred by Ambulance to Hospital
Swelling and tightness of right side of face (cheek), right leg paresthesia.
No adverse effects; Nurse reports one expired dose of MMR II was administered to patient; This spontaneous report was received from a Licensed Practical Nurse concerning to a patient of unknown age and gender.  The patient's pertinent medical history, previous drug reactions, allergies, and concomitant therapies were not reported.     On 05-JUN-2019, the patient was vaccinated with one expired dose of and recombinant human albumin (rHA) measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose and route of administration were not reported; lot # N008366 with expiration date 13-MAR-2019) for prophylaxis. No adverse effects reported.         Lot number and expiration date were reported in the source document. But, when entering the lot number in database the system automatically auto-populated the correct expiration date, which sometimes may differs from the expiration date reported by the source.
It hurt my arm muscle REALLY badly right as it was being administered. I passed out within 2 minutes due to the pain. (The first shot barely hurt a month earlier at the same vaccine distribution center.) EMT checked heart rate which dropped to 50 and blood pressure was up and down, but was "dangerously low."
A non-serious spontaneous report of expired FLUMIST inadvertently administered to a child was received from a health professional concerning a nine-year-old female. Neither medical history nor concomitant medication was reported for this patient. The product expired on 12-Dec-2010. On 13-Dec-2010, the patient received expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
Break out of cold sores....5 in all. Which is unusual since I have a break out once a year when I get a cold and it is only one blister not 5.
1 ? I had really bad headaches the night the vaccination was administered. 2 ? The next morning I had a REALLY bad ocular migraine when I woke up.   The duration was 24-36 hours.
Pt developed redness and swelling to neck, along with lightheadedness several minutes after injection. BP, pulse, oxygen saturation and breath sounds were all within normal limits. She denied any dyspnea or difficulty swallowing.  EMS was called promptly and pt was given Benadryl 50mg x1 while EMS was en route. Her symptoms remained stable and she was taken to the hospital by Rescue.
Myalgia, Fever, runny nose, chills, sore left arm, Narrative:
PATIENT STATES SHE STARTED HAVING A COUGH AND SOB 5 DAYS AFTER GETTING VACCINE
About an hour after her vaccine, patient called and said that she was nauseous, vomiting, had passed out twice, a rash from the injection site up to her throat, and her arm was swollen from the elbow up.  I told her to take Benadryl and to go to the ER or to the immediate care.  I followed up with her the next day and she went to the ER, she said the Benadryl helped her out significantly and that she was feeling much better that day.  She was still inquiring about the second shot but, she was following up with her MD on Wednesday.
I have experienced several odd olfactory odors or aromas from foods like peanut butter, cheddar cheese, bacon, tuna fish all seem to have the same rancid taste, smell or phantom aroma. I have the same slight head ache repeatedly. also my vision seems to have deteriorated somewhat. .
37 weeks pregnant the hospital says 38 but we know when we conceived. They say we are due May 21st but we know May 26th.
pt recvd vax 8JUL95 & 11JUL95 pt exp a upper resp infect & was treated w/Pred;No further details were provided;
Patient developed tachycardia to 170s and BP 160/100, headache, lightheaded, some difficulty breathing/shortness of breath but pt states it may be associated with the mask.
Patient calls today with what he believes is a reaction to his Shingrix #2 vaccine. Patient received the Shingrix #2 vaccine yesterday (10/19/2021). He notes that the first vaccine "didn't bother me much, just made me tired".  Initially after the vaccine he just had a sore arm but at 8pm he "started crashing and felt like hell". He says he experienced chills, nausea, muscle/joint pain, and a "strong" headache. It is worth noting he never had a fever. He describes "sharp pains" all the way down to his feet. He also wanted to document that later in the night he developed "severe" pain in his left arm where the #2 injection was given but also in his right arm "right where I  received the first vaccine". He found this strange. He tells writer that as of this morning his symptoms are a lot better and improving.
Information has been received from a registered nurse concerning a male patient who was vaccinated with PNEUMOVAX 23 subcutaneously. Subsequently the patient developed a severe localized injection site reactions while in the hospital for other health issues. The patient was not hospitalized because of injection site reaction, but rather, the reaction occurred while in the hospital for another issues. The patient had sought medical attention. At the time of report, the patient's outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
After the vaccines Patient gradually became more lethargic, sleepy and excessively drinking water. This went on for 2 years until it was out of hand and we noticed from his annual Pediatrician Visits that he was declining on his growth charts significantly. From being 85-90 percentile to 30 percentile in 2023.  This caused us to do some digging and return to Hospital in 2021 -2023 and in the beginning they told us his excessive thirst and bedwetting was for constipation and incontinence at bedtime. After nothing improved for over a year and half,  we started to see the Endocinologist and then went through excessive testing 03/2023- 08/2023
History of Present Illness:  Patient has a history of sinus problems.  He was schedule for sinuplasty and had preoperative evaluation on 04/21/2021 with WBC 5.8, Hb 15.5, PLT 193,000.  He had J&J covid vaccination on 04/27/2021. He underwent sinuplasty on 05/05/2021.  Subsequent to his surgery he was having headache.  He had some nasal discharge with blood.  He took tramadol but had persistent pain.  His symptoms were worsening up with some weakness of his right upper extremity.  Was having generalized fatigue and weakness.  He states he was getting short of breath with a flight of stairs.  He had decreased appetite.  He was given Vicodin for his headache with some improvement.  He noted discoloration and bruising with pain pain in his left internal thigh area.  Was noticing some changes in his vision but no loss of vision.  He presented to the ED on 05/11/2021 and laboratory showed WBC 8.7 Hb15.2, PLT 6,000, segs 77%, lymphs 9%.  He had no dark colored urine.  INR 1.4 PTT 33, immature platelets 30.2.  His bili was 2.1.  He was treated with dexamethasone 40 mg. There is tiny focus of restricted diffusion in the both cerebellar hemispheres measuring up to 0.4 cm white matter left cerebellar hemisphere of left parietal junction measuring 0.5 cm compatible small lacunar infarcts.  Chronic paranasal sinusitis.  Patient described minimal blood with flushing his sinuses.    Patient was ultimately transferred to Hospital after 3 days (on 5/11)  for further acute care management given the multiple clots and bleeds associated with severe thrombocytopenia.
Moderna vaccine dose #3 given from vial Lot # 021C21A 5 days after 30 days in refrigerator. No temperature excursion.  Vaccine given at 35 days after the refrigerated 30 day expiration recommendation.  RN notified Health Authority by email on 9-28-2021 and  second request on 10-19-2021 with recommendation to contact Moderna.  RN notified Moderna  requesting recommendation.  On 11-4-2021, Moderna reported in reference to Case ID CEA-1046, an analysis performed on Lot #021C21A and vaccine maintained the activity necessary to protect against the SARS-COV-2 virus at time of administration on 9-21-2021. Moderna also recommended a VAERS report..  Letter from Moderna attached to client VAR.
April 5 ,2021 I developed palpitations, light headedness, and a fast heart rate. I was in atrial fibrillation. I went to the ER at Hospital, and I saw an electrophysiology cardiologist. I was prescribed Eliquis 5mg, Diltiazem 180mg 1xday, and flecainide 15mg 2xday. My thyroid was low so I was referred to an endocrinologist. On 12/17/2021 and 12/30/2021 I had another episode of atrial fibrillation. I stopped taking Eliquis because I was prescribed to take Xarelto and my flecainide was increased to 100mg. I do have family history of heart disease and atrial fibrillation. My doctor will decide if I need an ablation. I am starting on a new medication tomorrow through ivn infusion my osteoporosis which is Reclast.
Patient felt dizzy and had very high blood pressure, felt like she was going to pass out, tired and no balance
Coughing; COVID-19; had the boosters this year on April and May; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19), COUGH (Coughing) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (had the boosters this year on April and May) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (had the boosters this year on April and May). In June 2022, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced COUGH (Coughing). At the time of the report, COVID-19 (COVID-19), COUGH (Coughing) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (had the boosters this year on April and May) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2022, SARS-CoV-2 test: (Positive) Positive.         No concomitant medication reported.  Patient received booster doses.  Patient asked for Moderna to not use citric acid in the formulation of the new booster to help people who had intolerance to citric acid.  It was reported that experienced coughing but did not run a fever.  No treatment medication reported.  Company comment: This spontaneous case concerns a 69 years-old female with no medical history, who experienced unexpected non serious AESI event covid-19, which occurred approximately 1 month after fourth dose of mRNA-1273 vaccine. Inappropriate schedule of product administration is also reported. SARS-CoV-2 test is Positive. patient experienced cough without fever. Outcome of the event reported as unknown. Current ongoing pandemia remains as confounder for the event covid-19. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.   This case was linked to MOD-2021-079664 (Patient Link).; Sender's Comments: This spontaneous case concerns a 69 years-old female with no medical history, who experienced unexpected non serious AESI event covid-19, which occurred approximately 1 month after fourth dose of mRNA-1273 vaccine. Inappropriate schedule of product administration is also reported. SARS-CoV-2 test is Positive. patient experienced cough without fever. Outcome of the event reported as unknown. Current ongoing pandemia remains as confounder for the event covid-19. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.
48 hr after Dtap and Prevnar pt developed fever, diarrhea, loss of appetite, staring spells.
today she presents 4 weeks after vaccines and swelling, redness, and heat have resolved but she notes there is still a bruise and a lump where shot was given. ecchymoses on left upper arm with subcut tender nodule, easily moveable/not connected to underlying muscle; no fluctuance. Reassured body will eventually reabsorb remaining subcut inflammation/nodule.
Shortness of breath; lightheadedness reported 13 minutes after injection. Symptoms resolved with a snack.   Vitals within normal limits. juice and crackers given.  Patient reports similar vasovagal reactions after blood draws and other injections.  Monitored for 45 minutes, symptoms resolved and released home.
This spontaneous report has been received from a Registered  Nurse refers to a 19 year old patient of unknown gender. The patient's concurrent conditions and pertinent medica history were not reported. On 16-AUG-2010, the patient was vaccinated with the first dose of VAQTA, (Lot #, exp. date, strength and dose were nor provided). On 17-JUL-2015, the patient was administered the second doe of VAQTA, (Lot #, exp. date , strength and dose were not provided). The reporting nurse stated that the second dose was a pediatric dose rather than the indicated adult dose. No adverse effects were reported. A product quality complaint was not involved. Additional information has been requested.
4:30 a.m. woke to sharp chest pain that continued throughout the day, late afternoon pain radiated across my chest and back.  Advised by MD to take 4 aspirin and 2 Tylenol every 4 hours.  12:40 a.m. Saturday, woke to swollen tongue (took Benadryl), loss of movement and feeling on complete right side.  Resting pulse 178.  After few hours, gained movement in toes and worked through arm and leg movement.  Could not hold a pen or fork for the next 24 hours.  Right sided weakness continued, in both right leg and arm.  With therapy exercises able to gain most strength back now scheduling to cardiac testing for periodic fast/fluttering heart rate, light headedness.  By October 27, tingling and pain in right arm subsided and no longer dragging right leg.
pt recv vax 5JUN98 & same day pt presented w/urticaria, inj site welts & difficulty breathing;pt was treated in MD office;
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 02-JAN-2017, the patient was vaccinated with an expired RECOMBIVAX HB, lot number L008660, expiration date 10-NOV-2016, (route and anatomical location were not reported), for prophylaxis. The reporter also stated that the RECOMBIVAX HB did not have any previous temperature excursions. No adverse symptoms were reported. Product quality complain was not involved. Additional information has been requested.
Immediate swelling, erythema & tenderness 1 1/2" x 1 1/2" after vaccine was given. BENADRYL was given.
This spontaneous report was received from a pharmacist and refers to a 61 year old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reaction or allergies and concomitant therapies was provided. On an unspecified date in October 2015, the patient was vaccinated with the first dose of an unidentified Merck HPV vaccine (name, lot number, exact dose and route of administration were not provided). On an unspecified date in November 2015, the patient was vaccinated with the second dose of an unidentified Merck HPV vaccine (name, lot number, exact dose and route of administration were not provided). No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
12 days after first shot----on 3/21 Bells Palsy---put on Prednisone and Valacyclov-----seeing Primary on 3/24/2021......
Right side chest pain, extreme fatigue, headache, burning in all joints especially knees, extreme leg pain
Post vax, the pt developed a varicella-like rash at the injection site and one lesion on back. Some redness and mild swelling at injection site which resolved after 4 days. Took Benadryl for itching.
4 months in between the two doses; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (4 months in between the two doses) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (4 months in between the two doses). On 31-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (4 months in between the two doses) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  The action taken with mRNA-1273 (MODERNA COVID-19 Vaccine) (Unknown) was unknown.
This medically confirmed report (initial receipt on 18-Sep-2013) concerns a female patient who had a history of egg allergy. On an unspecified date "many years ago", the patient received an unspecified flu vaccine (manufacturer and batch number not specified). On an unspecified date, the patient experienced an unspecified reaction to the vaccine. The patient's physician determined that the patient had a reaction to it because she had an egg allergy. The patient required medical attention and therefore she went to the hospital. The outcome was reported as recovered.
This was my second Moderna shot.  I was fine after the shot except for some pain at the site of the shot.  On the second day I was extremely fatigued and nauseous all day.   I did not drink enough fluids, became dehydrated, and after 5:00 pm collapsed and was taken to a hospital for rehydration and tests.  The failure to remain hydrated was my error.  However, I did want to report to you my extreme fatigue and nausea on the second day.  I was in a hospital for two days, but mostly for testing about potential cardiovascular issues (since I have 7 stents).
Headaches on the top of the eyes and cranium for 7 days and not going away
This spontaneous report was received from a patient mother refers to her daughter as a female patient of unknown age. No pertinent medical history was reported. On an unknown date, the patient was vaccinated with GARDASIL (dose, route, lot # were not reported). On an unknown date, the patient experienced infection (type unspecified) that required an antibiotic. Also reported that the patient was 2 weeks behind from received the third dose of GARDASIL vaccine at the 6 month mark. On an unknown date, the patient experienced anxiety due to not being able to get the 3rd dose of GARDASIL vaccine right away. No Product Quality Complaint (PQC) was involved. Action taken was not applicable. The outcome of events was unknown. Causality was not assessed by the reporter. Additional information has been requested.
The day after his first Covid-19 shot, patient complaint of itchy face. No swelling, no rashes, no difficulty breathing. Mild and lasted 2 days. On 3rd day after the vaccine, symptoms resolved.
Red, swollen length 11 1/2 cm, width 8cm pt was told to ice 10 min a couple times a day, and use BENADRYL. RTC if no better.
Left arm became slightly warm with erythema and swelling. Dad called on 5/9/02 and stated that child had been quiet, less playful and sleeping more. Gave Cefzil 250 bid X 10 days.
Hot to touch, redness, swelling, no temp. Patient seen in office 5-13-15 given prescription for BACTRIM for 10 days.